$ABIO ARCA biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ARCA biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ARCA biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ARCA biopharma, Inc. for free.

CIK Number: 0000907654
IRS Number: 363855489
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: ABIO
Company Address: 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER 80020
Phone number: 720-940-2200
Former name: HYSEQ INC, date of change: 1997-06-10
Former name: NUVELO INC, date of change: 2003-02-03

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Market Capitalization: $23.40M
Prev close: $2.60
Average Daily Volume: 34,121
Days Low: $2.55
Year Low: $2.15
Year High: $4.35

ARCA biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 17 2017ABIOARCA biopharma, In ...CONWAY ROBERT EDirectorBuyP2.4910,00024,90035,00025 K to 35 K (+40.00 %)
May 03 2017ABIOARCA biopharma, In ...MITCHELL DANIEL JDirectorBuyP2.7111,00029,81011,0000 to 11 K
Apr 05 2017ABIOARCA biopharma, In ...Selby Brian L.VP, FinanceSellS2.461,1142,7401,2752.4 K to 1.3 K (-46.63 %)
Apr 05 2017ABIOARCA biopharma, In ...Ozeroff Christopher DavidS.V.P., General Cou ...SellS2.414181,00717,51717.9 K to 17.5 K (-2.33 %)
Apr 05 2017ABIOARCA biopharma, In ...Keuer Thomas AChief Operating Off ...SellS2.4139094014,04514.4 K to 14 K (-2.70 %)
Apr 05 2017ABIOARCA biopharma, In ...BRISTOW MICHAEL RPres. & Chief Execu ...SellS2.417201,73541,15541.9 K to 41.2 K (-1.72 %)
Mar 27 2017ABIOARCA biopharma, In ...CONWAY ROBERT EDirectorBuyP2.5925,00064,75025,0000 to 25 K
Mar 01 2017ABIOARCA biopharma, In ...Selby Brian L.VP, FinanceOption ExerciseA2.6024,10062,66024,100
Mar 01 2017ABIOARCA biopharma, In ...Selby Brian L.VP, FinanceSellS2.561614122,3892.6 K to 2.4 K (-6.31 %)
Mar 01 2017ABIOARCA biopharma, In ...BRISTOW MICHAEL RPres. & Chief Execu ...Option ExerciseA2.6041,600108,16041,600
Mar 01 2017ABIOARCA biopharma, In ...BRISTOW MICHAEL RPres. & Chief Execu ...SellS2.617631,99141,87542.6 K to 41.9 K (-1.79 %)
Feb 21 2017ABIOARCA biopharma, In ...Grais Linda SDirectorOption ExerciseA2.508,00020,0008,000
Feb 21 2017ABIOARCA biopharma, In ...MITCHELL DANIEL JDirectorOption ExerciseA2.508,00020,0008,000
Feb 21 2017ABIOARCA biopharma, In ...Selby Brian L.VP, FinanceOption ExerciseA2.5023,00057,50023,000
Feb 21 2017ABIOARCA biopharma, In ...Ozeroff Christopher DavidS.V.P., General Cou ...Option ExerciseA2.5024,00060,00024,000

View all ARCA biopharma, Inc. insider transactions.